Sign in
ABCL-612 Real-World Outcomes in Patients With Relapsed or Refractory (r/r) Aggressive Large B-Cell Lymphoma (LBCL) Treated With Chemo-Immunotherapy
Journal article   Peer reviewed

ABCL-612 Real-World Outcomes in Patients With Relapsed or Refractory (r/r) Aggressive Large B-Cell Lymphoma (LBCL) Treated With Chemo-Immunotherapy

Loretta J. Nastoupil, Clark Andersen, Amy Ayers, Yucai Wang, Thomas M. Habermann, Dai Chihara, Brad S. Kahl, Brian K. Link, Sabarish Ayyappan, Jonathon B. Cohen, …
Clinical lymphoma, myeloma and leukemia, Vol.23, pp.S442-S443
2023-09

Metrics

1 Record Views

Details